Cargando…

Regulated resurfacing of a somatostatin receptor storage compartment fine-tunes pituitary secretion

The surfacing of the glucose transporter GLUT4 driven by insulin receptor activation provides the prototypic example of a homeostasis response dependent on mobilization of an intracellular storage compartment. Here, we generalize this concept to a G protein–coupled receptor, somatostatin receptor su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshafie, Walaa, Francis, Vincent, Bednarz, Klaudia, Pan, Yingzhou Edward, Stroh, Thomas, McPherson, Peter S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039187/ https://www.ncbi.nlm.nih.gov/pubmed/31825461 http://dx.doi.org/10.1083/jcb.201904054

Ejemplares similares

Ultradian Secretion of Growth Hormone in Mice: Linking Physiology With Changes in Synapse Parameters Using Super-Resolution Microscopy
por: Bednarz, Klaudia, et al.
Publicado: (2020)

The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
por: Zgliczyński, Wojciech, et al.
Publicado: (2013)

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas
por: Wang, Ji-wen, et al.
Publicado: (2014)

The ARSACS disease protein sacsin controls lysosomal positioning and reformation by regulating microtubule dynamics
por: Francis, Vincent, et al.
Publicado: (2022)

Correction: The ARSACS disease protein sacsin controls lysosomal positioning and reformation by regulating microtubule dynamics
por: Francis, Vincent, et al.
Publicado: (2022)

The identification of high-performing antibodies for Coiled-coil-helix-coiled-coil-helix domain containing protein 10 (CHCHD10) for use in Western Blot, immunoprecipitation and immunofluorescence
por: Ayoubi, Riham, et al.
Publicado: (2023)

A Rare Case of Thyrotropin Secreting Pituitary Macroadenoma Primarily Treated With Somatostatin Analogue
por: Elsheikh, Arwa Mahmoud, et al.
Publicado: (2021)

Long-term effects of somatostatin analogues in rat GH-secreting pituitary tumor cell lines
por: Dicitore, A., et al.
Publicado: (2021)

Identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence
por: Ayoubi, Riham, et al.
Publicado: (2023)

Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas
por: Araujo-Castro, Marta, et al.
Publicado: (2020)

The identification of high-performing antibodies for Charged multivesicular body protein 2b for use in Western Blot, immunoprecipitation and immunofluorescence
por: Alshafie, Walaa, et al.
Publicado: (2023)

Plasmonic labeling of subcellular compartments in cancer cells: multiplexing with fine-tuned gold and silver nanoshells
por: Sobral-Filho, R. G., et al.
Publicado: (2017)

Regulating Glucagon Secretion: Somatostatin in the Spotlight
por: Rutter, Guy A.
Publicado: (2009)

Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center
por: Liu, Jie, et al.
Publicado: (2022)

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
por: Kim, Jean, et al.
Publicado: (2020)

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes
por: Bianchi, Antonio, et al.
Publicado: (2013)

Tuning and Fine-Tuning of Synapses with Adenosine
por: Sebastião, A.M, et al.
Publicado: (2009)

Identification of highly specific antibodies for Serine/threonine-protein kinase TBK1 for use in immunoblot, immunoprecipitation and immunofluorescence
por: Alshafie, Walaa, et al.
Publicado: (2022)

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement
por: Peverelli, Erika, et al.
Publicado: (2015)

The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
por: Colao, Annamaria, et al.
Publicado: (2015)

Case of Diabetes Mellitus, Associated with Lesions of the Pituitary Body
por: McPherson, Evelyn
Publicado: (1939)

SAT-LB24 Association of Expression of Somatostatin Receptor 2 Subtype in Non-Pituitary Neuroendocrine Tumors With Response to Treatment With Somatostatin Analogues
por: Siddiqui, Abdullah, et al.
Publicado: (2020)

Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1 – molecular pathways
por: Cakir, Mehtap, et al.
Publicado: (2010)

Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2 – clinical implications
por: Cakir, Mehtap, et al.
Publicado: (2010)

MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019)

Melatonin mediates monochromatic light-induced expression of somatostatin in the hypothalamus and pituitary of chicks
por: Qin, Xiaojing, et al.
Publicado: (2021)

Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Yu, Benxia, et al.
Publicado: (2017)

Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity
por: Blechman, Janna, et al.
Publicado: (2013)

Fine-tuning helper Ts
por: Maxmen, Amy
Publicado: (2009)

The fine-tuning price of LEP
por: Chankowski, Piotr H., et al.
Publicado: (1997)

Fine-tuning in the physical universe
por: Sloan, David, et al.
Publicado: (2020)

Fine-tuning Metabolic Switches
por: Sedwick, Caitlin
Publicado: (2013)

The varicocele argument resurfaces
por: Silber, Sherman
Publicado: (2018)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
por: Saksis, Rihards, et al.
Publicado: (2023)

Somatostatin-secreting Pheochromocytoma Mimicking Insulin-dependent Diabetes Mellitus
por: Hirai, Hiroyuki, et al.
Publicado: (2016)

Distinct mechanisms of hypoglycaemia in patients with somatostatin‐secreting neuroendocrine tumours
por: Wiesli, Peter, et al.
Publicado: (2019)

Retracted: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Song, Hao, et al.
Publicado: (2018)

Clinical effectiveness of patellar resurfacing, no resurfacing and selective resurfacing in primary total knee replacement: systematic review and meta-analysis of interventional and observational evidence
por: Grela, Michal, et al.
Publicado: (2022)

A Narrative Review of Patellar Resurfacing Versus Non-resurfacing in Total Knee Arthroplasty
por: Iordache, Sergiu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lo5gq01k2jpisfn3uu8popm7r5